Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in severe sepsis
PACTR202412745051519Phase 0Recruiting
- Sponsor
- amr sobhy
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of fluoxetine in sepsis (2 arms), sponsored by amr sobhy. Primary endpoints: Need for vasopressor and inotropic support and Duration of vasopressor and inotropic support. Started Dec 2024; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
sepsis
Beyond the preview
Go deeper on PACTR202412745051519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412745051519.